Market Research Report
In-Vitro Diagnostics (IVD) Market Research Report, By Product & Services (Reagents & Kits, Instruments, Data management software), By Applications (Infectious Diseases,Non-infectious diseases), By End User- Global Forecast Till 2023
|Published by||Market Research Future||Product code||818046|
|Published||Content info||206 Pages
Delivery time: 1-2 business days
|In-Vitro Diagnostics (IVD) Market Research Report, By Product & Services (Reagents & Kits, Instruments, Data management software), By Applications (Infectious Diseases,Non-infectious diseases), By End User- Global Forecast Till 2023|
|Published: March 1, 2019||Content info: 206 Pages||
In-vitro diagnostics (IVD) are medical devices, reagents, and accessories used to perform tests on samples, (e.g., blood, urine, and tissue) taken from the human body to help detect infection, diagnose a medical condition, and prevent disease. The aging population and the increasing prevalence of cancer and infectious diseases in developing countries, rising acceptance of molecular diagnostics in personalized medicines, change in lifestyle, increasing prevalence of chronic diseases, and an increasing number of private diagnostic centers drive the growth of the global in-vitro diagnostics market. Cardiovascular diseases (CVD) are considered as the biggest cause of death globally with an estimated 17.7 million deaths by CVD in 2015, representing 31% of all the global deaths as per the World Health Organization (WHO) statistics.
The global in-vitro diagnostics market is expected to reach a market value of USD 1,02,555 million by 2023 from USD 64,390 million in 2017 and is expected to register a CAGR of 8.16% during the forecast period from 2018 to 2023. In 2017, the market was led by the Americas with a 39.4% share, followed by Europe with a share of 31.32%. The market growth in the Americas is attributed to the increase in the population suffering from chronic diseases.
The global in-vitro diagnostics market has been segmented based on products and services, technology, application, end user, and region.
The global in-vitro diagnostics market, by products and services, has been segmented into reagents and kits, instruments, and data management software and services.
The global in-vitro diagnostics market, by technology, has been segmented into clinical chemistry, immunoassay/immunochemistry, molecular diagnostics, microbiology, hematology, and others.
The global in-vitro diagnostics market, by application, has been segmented into infectious diseases and non-infectious diseases.
By end user, the global in-vitro diagnostics market has been segmented into hospitals, laboratories, academic institutes, and others.
F. Hoffmann-La Roche AG, Danaher Corporation, Abbott Laboratories, Siemens, and Thermo Fisher Scientific.